IMPORTANCE: Granulin (GRN) mutations represent one of the most frequent genetic causes of inherited frontotemporal dementia. The study of asymptomatic carriers of GRN Thr272fs mutation (aGRN+) provides a unique opportunity to study the natural history of the disease and the role of modulating factors on disease onset. It has been demonstrated that the TMEM106B polymorphism is associated with GRN-related frontotemporal dementia and affects age at onset in GRN mutation carriers. OBJECTIVE: To ascertain whether TMEM106B genetic status modulates GRN disease by evaluating resting-state functional connectivity in aGRN+ individuals according to TMEM106 genetic variation. DESIGN, SETTING, AND PARTICIPANTS: Academic tertiary referral center for neurodegenerative disorders in 17 asymptomatic carriers of aGRN+ and 14 healthy controls. MAIN OUTCOMES AND MEASURES: Changes in resting-state functional connectivity, focusing on the default mode network, ventral and dorsal salience networks, executive network, frontoparietal networks, and attentive network and the effect of TMEM106B genotypes in aGRN+ participants and healthy controls (statistical nonparametric mapping). RESULTS: aGRN+ participants showed decreased brain connectivity within the left frontoparietal network and increased connectivity in the executive network compared with healthy controls. The TMEM106B at-risk polymorphism (T/T) was associated with decreased connectivity within the ventral salience network (ie, middle frontal gyrus) and the left frontoparietal network (ie, left precuneus). CONCLUSIONS AND RELEVANCE: This study suggests that the TMEM106B polymorphism modulates brain connectivity in aGRN+ individuals, with additional damage of the ventral salience network and left frontoparietal network observed. Genotyping TMEM106B is of importance in aGRN+ individuals for prognostic purposes and to assess early brain damage.
IMPORTANCE: Granulin (GRN) mutations represent one of the most frequent genetic causes of inherited frontotemporal dementia. The study of asymptomatic carriers of GRN Thr272fs mutation (aGRN+) provides a unique opportunity to study the natural history of the disease and the role of modulating factors on disease onset. It has been demonstrated that the TMEM106B polymorphism is associated with GRN-related frontotemporal dementia and affects age at onset in GRN mutation carriers. OBJECTIVE: To ascertain whether TMEM106B genetic status modulates GRN disease by evaluating resting-state functional connectivity in aGRN+ individuals according to TMEM106 genetic variation. DESIGN, SETTING, AND PARTICIPANTS: Academic tertiary referral center for neurodegenerative disorders in 17 asymptomatic carriers of aGRN+ and 14 healthy controls. MAIN OUTCOMES AND MEASURES: Changes in resting-state functional connectivity, focusing on the default mode network, ventral and dorsal salience networks, executive network, frontoparietal networks, and attentive network and the effect of TMEM106B genotypes in aGRN+ participants and healthy controls (statistical nonparametric mapping). RESULTS:aGRN+ participants showed decreased brain connectivity within the left frontoparietal network and increased connectivity in the executive network compared with healthy controls. The TMEM106B at-risk polymorphism (T/T) was associated with decreased connectivity within the ventral salience network (ie, middle frontal gyrus) and the left frontoparietal network (ie, left precuneus). CONCLUSIONS AND RELEVANCE: This study suggests that the TMEM106B polymorphism modulates brain connectivity in aGRN+ individuals, with additional damage of the ventral salience network and left frontoparietal network observed. Genotyping TMEM106B is of importance in aGRN+ individuals for prognostic purposes and to assess early brain damage.
Authors: Enrico Premi; Vince D Calhoun; Matteo Diano; Stefano Gazzina; Maura Cosseddu; Antonella Alberici; Silvana Archetti; Donata Paternicò; Roberto Gasparotti; John van Swieten; Daniela Galimberti; Raquel Sanchez-Valle; Robert Laforce; Fermin Moreno; Matthis Synofzik; Caroline Graff; Mario Masellis; Maria Carmela Tartaglia; James Rowe; Rik Vandenberghe; Elizabeth Finger; Fabrizio Tagliavini; Alexandre de Mendonça; Isabel Santana; Chris Butler; Simon Ducharme; Alex Gerhard; Adrian Danek; Johannes Levin; Markus Otto; Giovanni Frisoni; Stefano Cappa; Sandro Sorbi; Alessandro Padovani; Jonathan D Rohrer; Barbara Borroni Journal: Neuroimage Date: 2019-02-01 Impact factor: 6.556
Authors: Qin Chen; Bradley F Boeve; Matthew Senjem; Nirubol Tosakulwong; Timothy Lesnick; Danielle Brushaber; Christina Dheel; Julie Fields; Leah Forsberg; Ralitza Gavrilova; Debra Gearhart; Jonathan Graff-Radford; Neill Graff-Radford; Clifford R Jack; David Jones; David Knopman; Walter K Kremers; Maria Lapid; Rosa Rademakers; Eliana Marisa Ramos; Jeremy Syrjanen; Adam L Boxer; Howie Rosen; Zbigniew K Wszolek; Kejal Kantarci Journal: Neurobiol Aging Date: 2019-12-12 Impact factor: 4.673
Authors: Gianina Toller; Yann Cobigo; Peter A Ljubenkov; Brian S Appleby; Bradford C Dickerson; Kimiko Domoto-Reilly; Jamie C Fong; Leah K Forsberg; Ralitza H Gavrilova; Nupur Ghoshal; Hilary W Heuer; David S Knopman; John Kornak; Maria I Lapid; Irene Litvan; Diane E Lucente; Ian R Mckenzie; Scott M McGinnis; Bruce L Miller; Otto Pedraza; Julio C Rojas; Adam M Staffaroni; Bonnie Wong; Zbigniew K Wszolek; Brad F Boeve; Adam L Boxer; Howard J Rosen; Katherine P Rankin Journal: Neurology Date: 2022-05-18 Impact factor: 11.800
Authors: Michela Pievani; Nicola Filippini; Martijn P van den Heuvel; Stefano F Cappa; Giovanni B Frisoni Journal: Nat Rev Neurol Date: 2014-10-07 Impact factor: 42.937
Authors: Corey T McMillan; Jenny Russ; Elisabeth M Wood; David J Irwin; Murray Grossman; Leo McCluskey; Lauren Elman; Vivanna Van Deerlin; Edward B Lee Journal: Neurology Date: 2015-03-20 Impact factor: 9.910
Authors: Jonathan D Rohrer; Jennifer M Nicholas; David M Cash; John van Swieten; Elise Dopper; Lize Jiskoot; Rick van Minkelen; Serge A Rombouts; M Jorge Cardoso; Shona Clegg; Miklos Espak; Simon Mead; David L Thomas; Enrico De Vita; Mario Masellis; Sandra E Black; Morris Freedman; Ron Keren; Bradley J MacIntosh; Ekaterina Rogaeva; David Tang-Wai; Maria Carmela Tartaglia; Robert Laforce; Fabrizio Tagliavini; Pietro Tiraboschi; Veronica Redaelli; Sara Prioni; Marina Grisoli; Barbara Borroni; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Andrea Arighi; Giorgio Fumagalli; James B Rowe; Ian Coyle-Gilchrist; Caroline Graff; Marie Fallström; Vesna Jelic; Anne Kinhult Ståhlbom; Christin Andersson; Håkan Thonberg; Lena Lilius; Giovanni B Frisoni; Michela Pievani; Martina Bocchetta; Luisa Benussi; Roberta Ghidoni; Elizabeth Finger; Sandro Sorbi; Benedetta Nacmias; Gemma Lombardi; Cristina Polito; Jason D Warren; Sebastien Ourselin; Nick C Fox; Martin N Rossor; Giuliano Binetti Journal: Lancet Neurol Date: 2015-02-04 Impact factor: 44.182